Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
FPR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
RNF217 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CIDECP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
GPRC5C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CPSF4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC38A2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CARD16 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
ANXA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101927592 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C5orf49 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IGSF6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ABCC3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
F11R - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARID1B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZPLD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RORA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ITGA2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on